Goodrx Historical Balance Sheet

GDRX Stock

USD 4.56 0.08 1.72%

Trend analysis of Goodrx Holdings balance sheet accounts such as Other Current Liabilities of 102.6 M or Total Current Liabilities of 80.7 M provides information on Goodrx Holdings' total assets, liabilities, and equity, which is the actual value of Goodrx Holdings to its prevalent stockholders. By breaking down trends over time using Goodrx Holdings balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Goodrx Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Goodrx Holdings is a good buy for the upcoming year.

Goodrx Holdings Inventory

0.95

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Goodrx Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Goodrx Stock please use our How to Invest in Goodrx Holdings guide.

About Goodrx Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Goodrx Holdings at a specified time, usually calculated after every quarter, six months, or one year. Goodrx Holdings Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Goodrx Holdings and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Goodrx currently owns. An asset can also be divided into two categories, current and non-current.

Goodrx Holdings Balance Sheet Chart

At this time, Goodrx Holdings' Non Current Liabilities Total is fairly stable compared to the past year. Total Liabilities is likely to rise to about 773.3 M in 2025, whereas Total Assets are likely to drop slightly above 1.3 B in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Retained Earnings

Add Fundamental

Total Assets

Total assets refers to the total amount of Goodrx Holdings assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Goodrx Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Goodrx Holdings balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Goodrx Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most accounts from Goodrx Holdings' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Goodrx Holdings current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Goodrx Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Goodrx Stock please use our How to Invest in Goodrx Holdings guide.At this time, Goodrx Holdings' Non Current Liabilities Total is fairly stable compared to the past year. Total Liabilities is likely to rise to about 773.3 M in 2025, whereas Total Assets are likely to drop slightly above 1.3 B in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	717.0M	711.1M	56.7M	53.8M
Total Assets	1.6B	1.6B	1.4B	1.3B

Short Long Term Debt Total Total Assets

Goodrx Holdings balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		-0.41	0.77	0.91	0.99	0.17	0.98	0.94	0.97	-0.95	-0.96	0.77	0.96	0.91	0.32	0.86	-0.68	0.96	0.91	0.86	-0.99	0.88	-0.98	0.84	1.0	-0.98
Short Long Term Debt Total	-0.41		-0.87	-0.58	-0.5	-0.28	-0.56	-0.38	-0.48	0.64	0.58	-0.22	-0.27	-0.55	-0.97	-0.39	0.93	-0.27	-0.56	-0.62	0.51	-0.55	0.56	-0.57	-0.44	0.56
Other Current Liab	0.77	-0.87		0.89	0.82	0.28	0.87	0.72	0.8	-0.87	-0.87	0.66	0.63	0.87	0.83	0.65	-0.96	0.63	0.88	0.88	-0.83	0.84	-0.85	0.8	0.78	-0.84
Total Current Liabilities	0.91	-0.58	0.89		0.92	0.28	0.94	0.85	0.93	-0.88	-0.9	0.84	0.78	0.97	0.53	0.75	-0.81	0.78	0.99	0.96	-0.92	0.83	-0.94	0.88	0.92	-0.92
Total Stockholder Equity	0.99	-0.5	0.82	0.92		0.18	0.99	0.94	0.97	-0.97	-0.98	0.75	0.95	0.91	0.41	0.87	-0.75	0.95	0.91	0.87	-1.0	0.9	-0.99	0.86	0.99	-0.99
Other Liab	0.17	-0.28	0.28	0.28	0.18		0.22	-0.11	0.08	-0.18	-0.31	0.23	0.04	0.34	0.32	0.09	-0.19	0.04	0.27	0.41	-0.21	-0.03	-0.23	0.16	0.21	-0.22
Net Tangible Assets	0.98	-0.56	0.87	0.94	0.99	0.22		0.92	0.96	-0.97	-0.99	0.76	0.92	0.94	0.48	0.83	-0.79	0.92	0.93	0.9	-0.99	0.91	-0.99	0.85	0.99	-0.99
Property Plant And Equipment Net	0.94	-0.38	0.72	0.85	0.94	-0.11	0.92		0.98	-0.89	-0.86	0.69	0.91	0.85	0.29	0.85	-0.69	0.91	0.85	0.8	-0.92	0.91	-0.92	0.81	0.93	-0.92
Current Deferred Revenue	0.97	-0.48	0.8	0.93	0.97	0.08	0.96	0.98		-0.93	-0.91	0.72	0.9	0.93	0.4	0.87	-0.77	0.9	0.92	0.89	-0.96	0.88	-0.97	0.88	0.97	-0.97
Net Debt	-0.95	0.64	-0.87	-0.88	-0.97	-0.18	-0.97	-0.89	-0.93		0.96	-0.62	-0.91	-0.86	-0.54	-0.88	0.83	-0.91	-0.87	-0.84	0.98	-0.86	0.98	-0.88	-0.96	0.99
Retained Earnings	-0.96	0.58	-0.87	-0.9	-0.98	-0.31	-0.99	-0.86	-0.91	0.96		-0.77	-0.9	-0.91	-0.51	-0.81	0.78	-0.9	-0.9	-0.88	0.98	-0.9	0.97	-0.82	-0.96	0.97
Accounts Payable	0.77	-0.22	0.66	0.84	0.75	0.23	0.76	0.69	0.72	-0.62	-0.77		0.66	0.83	0.24	0.52	-0.46	0.66	0.85	0.77	-0.74	0.75	-0.72	0.63	0.76	-0.71
Cash	0.96	-0.27	0.63	0.78	0.95	0.04	0.92	0.91	0.9	-0.91	-0.9	0.66		0.77	0.16	0.88	-0.54	1.0	0.77	0.7	-0.95	0.81	-0.92	0.78	0.95	-0.93
Non Current Assets Total	0.91	-0.55	0.87	0.97	0.91	0.34	0.94	0.85	0.93	-0.86	-0.91	0.83	0.77		0.5	0.71	-0.79	0.77	0.98	0.99	-0.91	0.86	-0.92	0.79	0.92	-0.91
Non Currrent Assets Other	0.32	-0.97	0.83	0.53	0.41	0.32	0.48	0.29	0.4	-0.54	-0.51	0.24	0.16	0.5		0.35	-0.88	0.16	0.5	0.57	-0.43	0.49	-0.47	0.55	0.35	-0.47
Other Assets	0.86	-0.39	0.65	0.75	0.87	0.09	0.83	0.85	0.87	-0.88	-0.81	0.52	0.88	0.71	0.35		-0.63	0.88	0.69	0.66	-0.88	0.72	-0.88	0.92	0.87	-0.89
Long Term Debt	-0.68	0.93	-0.96	-0.81	-0.75	-0.19	-0.79	-0.69	-0.77	0.83	0.78	-0.46	-0.54	-0.79	-0.88	-0.63		-0.54	-0.8	-0.82	0.75	-0.77	0.79	-0.78	-0.71	0.79
Cash And Short Term Investments	0.96	-0.27	0.63	0.78	0.95	0.04	0.92	0.91	0.9	-0.91	-0.9	0.66	1.0	0.77	0.16	0.88	-0.54		0.77	0.7	-0.95	0.81	-0.92	0.78	0.95	-0.93
Net Receivables	0.91	-0.56	0.88	0.99	0.91	0.27	0.93	0.85	0.92	-0.87	-0.9	0.85	0.77	0.98	0.5	0.69	-0.8	0.77		0.97	-0.91	0.84	-0.92	0.81	0.91	-0.91
Good Will	0.86	-0.62	0.88	0.96	0.87	0.41	0.9	0.8	0.89	-0.84	-0.88	0.77	0.7	0.99	0.57	0.66	-0.82	0.7	0.97		-0.87	0.8	-0.9	0.77	0.88	-0.88
Common Stock Total Equity	-0.99	0.51	-0.83	-0.92	-1.0	-0.21	-0.99	-0.92	-0.96	0.98	0.98	-0.74	-0.95	-0.91	-0.43	-0.88	0.75	-0.95	-0.91	-0.87		-0.89	0.99	-0.87	-0.99	1.0
Common Stock Shares Outstanding	0.88	-0.55	0.84	0.83	0.9	-0.03	0.91	0.91	0.88	-0.86	-0.9	0.75	0.81	0.86	0.49	0.72	-0.77	0.81	0.84	0.8	-0.89		-0.87	0.71	0.86	-0.87
Non Current Liabilities Total	-0.98	0.56	-0.85	-0.94	-0.99	-0.23	-0.99	-0.92	-0.97	0.98	0.97	-0.72	-0.92	-0.92	-0.47	-0.88	0.79	-0.92	-0.92	-0.9	0.99	-0.87		-0.89	-0.99	1.0
Other Current Assets	0.84	-0.57	0.8	0.88	0.86	0.16	0.85	0.81	0.88	-0.88	-0.82	0.63	0.78	0.79	0.55	0.92	-0.78	0.78	0.81	0.77	-0.87	0.71	-0.89		0.86	-0.89
Other Stockholder Equity	1.0	-0.44	0.78	0.92	0.99	0.21	0.99	0.93	0.97	-0.96	-0.96	0.76	0.95	0.92	0.35	0.87	-0.71	0.95	0.91	0.88	-0.99	0.86	-0.99	0.86		-0.99
Total Liab	-0.98	0.56	-0.84	-0.92	-0.99	-0.22	-0.99	-0.92	-0.97	0.99	0.97	-0.71	-0.93	-0.91	-0.47	-0.89	0.79	-0.93	-0.91	-0.88	1.0	-0.87	1.0	-0.89	-0.99

Click cells to compare fundamentals

Goodrx Holdings Account Relationship Matchups

Goodrx Holdings balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.5B	1.6B	1.6B	1.6B	1.4B	1.3B
Short Long Term Debt Total	704.9M	702.3M	717.0M	711.1M	56.7M	53.8M
Other Current Liab	26.3M	38.0M	35.6M	64.2M	97.7M	102.6M
Total Current Liabilities	59.6M	81.1M	76.3M	122.6M	123.9M	80.7M
Total Stockholder Equity	711.4M	831.7M	814.8M	762.0M	724.7M	760.9M
Other Liab	3.0M	5.8M	5.4M	7.6M	8.7M	6.3M
Net Tangible Assets	(1.4B)	393.5M	831.7M	814.8M	937.1M	983.9M
Property Plant And Equipment Net	50.8M	49.3M	55.7M	45.9M	40.5M	43.6M
Current Deferred Revenue	6.9M	6.9M	7.9M	7.1M	8.2M	5.9M
Net Debt	(263.8M)	(238.8M)	(40.1M)	38.8M	(391.7M)	(372.1M)
Retained Earnings	(1.4B)	(1.4B)	(1.4B)	(1.5B)	(1.4B)	(1.5B)
Accounts Payable	10.3M	17.5M	17.7M	36.3M	14.1M	17.4M
Cash	968.7M	941.1M	757.2M	672.3M	448.3M	604.7M
Non Current Assets Total	383.7M	518.8M	684.9M	716.0M	728.8M	561.7M
Non Currrent Assets Other	2.0M	(34.3M)	(15.0M)	22.8M	148.3M	155.7M
Other Assets	3.4M	15.1M	6.0M	8.2M	9.4M	7.6M
Long Term Debt	659.9M	655.9M	651.8M	647.7M	486.7M	512.3M
Cash And Short Term Investments	968.7M	941.1M	757.2M	672.3M	448.3M	604.7M
Net Receivables	68.7M	126.4M	117.1M	160.0M	160.8M	113.7M
Good Will	261.1M	329.7M	412.1M	410.8M	472.4M	358.5M
Common Stock Shares Outstanding	391.7M	400.6M	412.9M	410.3M	392.2M	433.0M
Liabilities And Stockholders Equity	1.5B	1.6B	1.6B	1.6B	1.4B	1.3B
Non Current Liabilities Total	699.2M	694.8M	713.5M	704.3M	539.5M	714.6M
Capital Lease Obligations	38.0M	39.4M	58.2M	54.6M	51.7M	44.3M
Other Current Assets	48.9M	21.3M	16.0M	40.4M	50.1M	30.3M
Other Stockholder Equity	2.1B	2.2B	2.3B	2.2B	2.2B	1.7B
Total Liab	758.8M	775.9M	789.8M	826.8M	663.4M	773.3M
Net Invested Capital	1.4B	1.5B	1.5B	1.4B	1.2B	962.4M
Property Plant And Equipment Gross	50.8M	21.6M	19.8M	59.6M	58.7M	38.6M
Total Current Assets	1.1B	1.1B	919.7M	872.8M	659.3M	752.2M
Non Current Liabilities Other	5.8M	5.1M	7.6M	8.2M	6.8M	6.3M
Net Working Capital	1.0B	1.0B	843.4M	750.2M	535.4M	671.5M
Short Term Debt	16.1M	18.7M	15.2M	15.0M	10.6M	14.3M
Intangible Assets	56.7M	133.8M	189.9M	156.3M	52.1M	99.6M
Property Plant Equipment	34.2M	50.8M	21.6M	19.8M	22.8M	28.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Goodrx Stock Analysis

When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Goodrx Historical Balance Sheet

Goodrx Holdings Inventory

0.95

About Goodrx Balance Sheet Analysis

Goodrx Holdings Balance Sheet Chart

Total Assets

Total Current Liabilities

Retained Earnings

Goodrx Holdings balance sheet Correlations

Goodrx Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Goodrx Holdings balance sheet Accounts

Also Currently Popular

Additional Tools for Goodrx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 1.0	Common Stock Total Equity
Total Liab	+ 1.0	Non Current Liabilities Total
Total Stockholder Equity	+ 0.99	Total Assets
Net Receivables	+ 0.99	Total Current Liabilities

Common Stock Total Equity	- 1.0	Total Stockholder Equity
Total Liab	- 0.99	Other Stockholder Equity
Other Stockholder Equity	- 0.99	Non Current Liabilities Total
Other Stockholder Equity	- 0.99	Common Stock Total Equity
Total Liab	- 0.99	Net Tangible Assets
Non Current Liabilities Total	- 0.99	Net Tangible Assets